EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.10, sa.3, ss.296-298, 2012 (SCI-Expanded, Scopus)
The mammalian target of rapamycin inhibitors is commonly preferred for solid organs for transplantation. Although these drugs have various adverse effects, sirolimus-related lymphedema has been rarely reported.